HCES: The Healthy Cookie Energy Study: Understanding How Healthy Cookies Affect Mitochondrial Biology

Sponsor
Ohio State University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04677920
Collaborator
(none)
24
1
1
31.7
0.8

Study Details

Study Description

Brief Summary

The proposed research is an intervention and feasibility pilot trial designed to determine if short-term consumption of healthy cookies made with an oil rich in linoleic acid can influence mitochondria biology in white blood cells and muscle. The hypothesis of the study is that consuming 1 healthy cookie rich in linoleic acid each day for two weeks will improve mitochondrial biology in white blood cells and muscle.

Condition or Disease Intervention/Treatment Phase
  • Other: High Linoleic Acid Healthy Cookies
N/A

Detailed Description

Linoleic acid has many health benefits including altering body composition and energy metabolism, possibly through its impact on cardiolipin and mitochondria.

The investigators plan to test the central hypothesis and accomplish the overall objective of this research by pursuing the following four specific aims

Aim 1) To assess muscle biopsy yield with a micro biopsy needle

Aim 2) To determine the amount of peripheral blood mononuclear cells (PBMC) and muscle needed to measure mitochondria function

Aim 3) To assess the feasibility of measuring mitochondria function on fresh PBMC and muscle samples

Aim 4) To determine the effect of short-term healthy cookies made with linoleic acid rich oil on measures of mitochondrial function in white blood cells and muscle as well as their relationship to lipid composition of the blood, markers of metabolic health and markers of mitochondria biogenesis

Study Design

Study Type:
Interventional
Anticipated Enrollment :
24 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
THE HEALTHY COOKIE ENERGY STUDY: Understanding How Healthy Cookies Affect Mitochondrial Biology
Actual Study Start Date :
Sep 7, 2020
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
May 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Healthy Cookie Group

All participants in the study

Other: High Linoleic Acid Healthy Cookies
High Linoleic Acid Healthy Cookies (containing about 10g of grapeseed oil) 1 per day for 2 weeks

Outcome Measures

Primary Outcome Measures

  1. Changes in mitochondria function [Week 0 to Week 2]

    Mitochondria function measured in peripheral blood mononuclear cells and skeletal muscle

  2. Changes in cardiolipin species [Week 0 to week 2]

    Cardiolipin species in peripheral blood mononuclear cells and skeletal muscle

  3. Correlation of mitochondrial biology in blood and skeletal muscle [Week 0 and week 2]

    Correlation of mitochondria function and cardiolipin species in peripheral blood mononuclear cells and skeletal muscle

Secondary Outcome Measures

  1. Changes in fasting fatty acid levels [Week 0 to week 2]

    Linoleic acid content of fasting blood samples

  2. Correlation of fatty acids with mitochondrial function and cardiolipin species [Week 0 and week 2]

    Correlation of linoleic acid in blood with mitochondria function and cardiolipin species in peripheral blood mononuclear cells and skeletal muscle

  3. Correlation of cardiolipin with global sleep quality score, Cambridge physical activity index and dietary intake of omega-3 fats [Week 0 and week 2]

    Correlation of cardiolipin in peripheral blood mononuclear cells and skeletal muscle with measurements of sleep quality using the Pittsburgh Sleep Quality Index, physical activity using the Epic Physical activity short questionnaire and dietary omega-3 intake using the Omega-3 Checklist

  4. Correlation of cardiolipin with body mass index, sagittal diameter (abdominal thickness), walking speed and grip strength [Week 0 and week 2]

    Correlation of cardiolipin in peripheral blood mononuclear cells and skeletal muscle with measurements of body mass index, sagittal diameter, grip strength and gait speed

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Nonsmoker
Exclusion Criteria:
  • Allergy/intolerance to lidocaine

  • Gastrointestinal diseases or disorders (including pancreatic) or gastric bypass surgery

  • Food Allergy or Intolerance

  • Any dietary restriction where consumption of these healthy cookies or any ingredient would be contraindicated

  • Use of medications where consuming the healthy cookies would be contraindicated

  • Pregnancy

  • Use of anticoagulant, antiplatelet, or other blood thinner medications

  • Diabetes

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Ohio State University Columbus Ohio United States 43210

Sponsors and Collaborators

  • Ohio State University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Martha Belury, Associate Professor, Ohio State University
ClinicalTrials.gov Identifier:
NCT04677920
Other Study ID Numbers:
  • 2020H0352
First Posted:
Dec 21, 2020
Last Update Posted:
Jan 20, 2022
Last Verified:
Jan 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No

Study Results

No Results Posted as of Jan 20, 2022